Functional role of insulin-like growth factor binding proteins

Hormone Research in Paediatrics

Volumn 48, Issue 4, 1997, Pages 9-15

  Ranke, M B ^a   Elmlinger, M ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Catabolic states; Chronic renal failure; Growth hormone deficiency; Insulin like growth factor binding protein determination; Insulin like growth factor binding protein structures; Insulin like growth factor binding proteins; Laron syndrome

Indexed keywords

CARRIER PROTEIN; GROWTH HORMONE; INSULIN; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

CANCER; CELL DIFFERENTIATION; CELL DIVISION; CELL SURFACE; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; EXTRACELLULAR MATRIX; FETUS DEVELOPMENT; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; INSULIN RELEASE; LARON SYNDROME; METABOLISM; NONHUMAN; NUTRITION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

ANIMALS; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MATERNAL-FETAL EXCHANGE; MODELS, BIOLOGICAL; NEOPLASMS; NUTRITIONAL STATUS; PREGNANCY;

EID: 0030723305     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000191304     Document Type: Article

References (54)

1. Drop SLS, Schuller AGP, Lindenbergh-Kort-leve DJ. Groffen C. Brinkman A, Zwarthoff EC: Structural aspects of the IGFBP family. Growth Regul 1992;2:69-79.
2. Clemmons DR: IGF-binding proteins: Regulation of cellular actions. Growth Regul 1992;2: 80-87.
3. Baxter RC: Insulin-like growth factor binding proteins in the human circulation: A review. Horm Res 1994;42:140-144.
4. Cohen P, Rosenfeld RG: Physiologic and clinical relevance of the insulin-like growth factor binding proteins. Curr Opin Pediatr 1994;6: 462-467.
5. Jones JI, Clemmons DR: Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 1995;16:3-34.
6. Zapf J: Physiological role of the insulin-like growth factor binding proteins. Eur J Endocrinol 1995;132:645-654.
7. LeRoith D: Insulin-like growth factor receptors and binding proteins. Baillière's Clin Endocrinol Metab 1996:10:49-73.
8. Salmon WD Jr, Daughaday WH: A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 1957;49:825-836.
9. Froesch F.R. Müller WA. Bürgi H: Nonsupprcs-sible insulin-like activity of human serum. II. Biological properties of plasma extracts with nonsuppressible insulin-like activity. Biochim BiophysActa 1966:121:360-374.
10. Daughaday WH, Hall K, Raben MS, Salmon WD, van den Brande JL, VanWyk JJ: Somatomedin: Proposed designation for sulphation factor. Nature 1972;235:107-108.
11. Hall K: Human somatomedin: Determination, occurrence, biological activity and purification. Acta Endocrinol (Copenh) 1972,163 (Suppl): 1052.
12. Van Wyk JJ. Underwood LE, Baseman JB. Hintz RL, Clemmons DR. Marshall RN: Explorations of the insulin-like and growth promoting properties of somatomedin by membrane receptor assays. Adv Metab Disord 1975; 8:127-150.
13. Rinderknechl E, Humbel RE: The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 1978:253:2769-2776.
14. Rinderknechl E, Humbel RE: Primary structure of human insulin-like growth factor II. FEBS Lett 1978;89:283-286.
15. Massague J. Czech MP: The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. J Biol Chem 1982:257:5038-5045.
16. Zapf J. Schmid CH. Froesch ER: Biological and immunological properties of insulin-like growth factors (IGF) I and II. Clin Endocrinol Metab 1984;13:3-30.
17. Oh Y. Müller HL. Neely EK. Lamson G, Rosenfeld RG: New concepts in insulin-like growth factor receptor physiology. Growth Regul 1993;3:113-123.
18. LeRoith D, Werner H. Beitner-Johnson D, Roberts CT Jr: Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 1995;16:143-163.
19. Ullrich A, Gray A. Tam AW. Yang-Feng T, Tsubokawa S. Collins C. Henzel W. Le Bon T. Kathuria S. Chen E. Jacobs S. Franke U. Ra-machandran J, Fujita-Yamaguchi Y: Insulinlike growth factor I receptor primary structure: Comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 1986:5:2503-2512.
20. Zapf J. Waldvogel M. Froesch ER: Binding of nonsuppressible insulin-like activity to human serum: Evidence for a carrier protein. Arch Biochcm Biophys 1975;168:638-645.
21. Hintz RL, Orsini F.M. Van Camp MG: Evidence for a somatomedin binding protein in plasma. The Endocrine Society 1974: Endocrinology 1974;(Suppl 94):A71.
22. Ballard FJ, Baxter RC, Binoux M, Clemmons D, Hall K, Drop S, Hintz RL, Redder M, Rutanen E, Schwander J: On the nomenclature of the IGF binding proteins. Acta Endocrinol 1989:121:751-752.
23. Shimasaki S. Ling N: Identification and molecular characterization of insulin-like growth factor binding proteins (1GFBP-I. -2. -3, -4, -5 and -6). Progr Growth Factor Res 1991:3:243-266.
24. Povoa G. Enberg G. Jomvall H. Hall K: Isolation and characterization of a somatomedin-binding protein from mid-term human amniotic fluid. Eur J Biochcm 1984:144:199-204.
25. Schwander J, Kuto E, Mary JL. Ritz L: The gene regulation of insulin-like growth factor binding protein-2 (1GFBP-2); in Baxter RC. Gluckman PD. Rosenfeld RG (eds): The insulin-like growth factors and their binding proteins. Amsterdam. Excerpta Medica. 1994. pp 151-161.
26. Martin JL. Baxter RC: Insulin-like growth factor binding protein from human plasma. Purification and characterization. J Biol Chem 1986;261:8754-8760.
27. McCusker RH, Camacho-Hubner C, Bavnc ML, Cascieri MA, Clemmons DR: Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: The modulating effect of cell released IGF binding proteins (IGFBPs). J Cell Physiol 1990:144:244-253.
28. Rechlcr MM. Brown AL: Insulin-like growth factor binding proteins: Gene structure and expression. Growth Regul 1992;2:55-68.
29. Han VKM, Asano H, Matsell DG, Delhanty PJD, Havalsu J, Basset N, Phillips ID, Nygard K, Stepaniuk O: Insulin-like growth factors (IGFs) and IGF binding proteins (IGFBPs) in fetal development: Physiology and pathophysiology; in Baxter RC. Gluckman PD. Rosenfeld RG (eds): The insulin-like growth factors and their regulatory proteins. Int Congr Series 1056. Amsterdam. Excerpta Medica, 1994, pp 263-283.
30. Pintar JE, Schuller A, Cerro JA, Czick M, Gre-wal A. Green B: Genetic ablation of IGFBP-2 suggests functional redundancy in the IGFBP family; in Blum WF. Hall K. (eds): Proceedings of the Third International Symposium on IGF Binding Proteins. Progr Growth Factor Res 1995:6:437-445.
31. Baxter RC. Martin JL: Structure of the Mr 140.000 growth hormone-dependent insulin-like growth factor binding protein complex: Determination by reconstitution and affinity-labeling. Proc Nall Acad Sci USA 1989:86: 6898-6902.
32. Martir JL, Baxter RC: Insulin-likc growth factor binding protein-3: Biochemistry and physiology. Growth Reg 1992:2:88-99.
33. Straus DS, Hayden JM, Marten NW: Molecular mechanisms for nutritional regulation of genes for IGF-I. IGF-binding proteins and other plasma proteins; in Baxter RC, Gluckman PD. Rosenfeld RG (eds): The insulin-like growth factors and their binding proteins. Amsterdam. Excerpta Medica. 1994. pp 33-41.
34. Lcong SR. Baxter RC, Cameralo T. Dai J, Wood WI: Structure and functional expression of the acid-labile subunit of the insulin-like growth factor-binding protein complex. Mol Endocrinol 1992;6:870-876.
35. Hall K, Brisntar K, Degerblad M, Ehrenborg E, Gutniak M, Luthman H, Povoa G: Serum levels of 25k IGF binding protein and their regulation: in Drop SLS. Hintz RL (eds): Insulin-like Growth Factor Binding Proteins. Int Congr Scries 881. Amsterdam. Exccrpta Medica, 1989. Pp 21-26.
36. Brismar K. Hilding A. Lindgren B: Regulation of IGFBP-I in humans; in Blum WF. Hall K (eds): Proceedings of the 3rd International Symposium on IGF Binding Proteins. Progr Growth Factor Res 1995;6:449-456.
37. Conover CA. Powell DR: Insulin-like growth factor (IGF) binding protein 3 blocks IGF-I-induccd receptor down regulation and cell de-sensitization in cultured bovine fibroblasts. Endocrinology 1991;129:710-716.
38. Blum WF. Jenne EW, Reppin F, Kictzmann K. Ranke MB. Bierich JR: Insulin-like growth factor 1 (IGF-I) binding protein complex is a better mitogen than free IGF-I. Endocrinology 1989; 125:766-772.
39. Chcvallcy T, Strong DD, Mohan S, Baylink D, Linkhart TA: Evidence for a role for insulin-likc growth factor binding proteins in glucocorticoid inhibition of normal human osteoblastlike cell proliferation. Eur J Endocrinol 1996; 134:591-601.
40. Hosscnlopp P, Segovia B, Lassarre C, Roghani M, Bredon M, Binoux M: Evidence of enzymatic degradation of insulin-like growth factor binding proteins in the I50K complex during pregnancy. J Clin Endocrinol Metab 1990:71: 797-805.
41. Rajah R. Katz L, Nunn S, Solberg P, Beers T, Cohen P: Insulin-like growth factor binding protein (IGFBP) proteases: Functional regulators of cell growth: in Blum WF, Hall K (eds): Proceedings of the 3rd International Symposium on IGF Binding Proteins. Progr Growth Factor Res 1995;6:273-284.
42. Jones JI. D’Ercole AJ. Camacho-Hubner C. Clemmons DR: Phosphorylation of insulinlike growth factor (IGF)-binding protein 1 in cell culture and in vivo: Effects on affinity for IGF-I. Proc Natl Acad Sci USA 1991.88:7481-7485.
43. Jones JI. Gockerman A, Busby WH. Wright G. Clemmons DR: Insulin-like growth factor binding protein I stimulates migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA 1993-90:10553-10557.
44. Booth BA, Boes M, Andress DL, Dake BL, Kiefer MC, Maack C, Linhardt RJ. Bar K. Caldwell EE. Weilcr J. Bar RS: IGFBP-3 and IGFBP-5 association with endothelial cells: Role of C-terminal heparin binding domain. Growth Regul 1995;5:1-17.
45. Lalou C. Lassarre C. Binoux M: A proteolytic fragment of insulin-like growth factor (IGF) binding protein 3 that fails to bind IGF is a cell growth inhibitor, in Blum WF. Hall K (eds): Proceedings of the Third International Symposium on IGF Binding Proteins. Progr Growth Factor Res 1995:6:311-316.
46. Blum WF, Albertsson-Wikland K, Rosberg K, Ranke MB: Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Mctab 1993;76:1610-1616.
47. Blum WF. Ranke MB. Kietzmann K, Gauggel E. Zeisel HJ, Bierich JR: A specific radioimmunoassay for the growth hormone (GH)-depcn-dent somatomedin-binding protein: Its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 1990;70:1292-1298.
48. Juul A, Main K, Blum WF, Lindholm J, Ranke MB, Skakkeback NE: The ratio between serum levels of insulin-like growth factor IGFH and the IGF binding proteins (IGFBP-1. 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clin Endocrinol 1994;41:85-93.
49. Blunt WF, Ranke MB. Savage MO. Hall K: Insulin-like growth factors and their binding proteins in patients with growth hormone receptor deficiency: Suggestions for new diagnostic criteria. Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes. Acta Paedialr 1992:383(suppl): 125-126.
50. Ranke MB. Savage MO. Chatelain PG. Preece MA. Rosenfeld RG, Blum WF. Wilton P. Insulin-like growth factor I improves height in growth hormone insensitivity: Two years' results. Horm Res 1995:44:253-264.
51. Blum WF, Ranke MB, Kietzmann K, Tonshoff B, Mehls O: Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia. Pediatr Nephrol 1991:5:539-544.
52. Baxter RC: The role of insulin-like growth factors and their binding proteins in tumor hypoglycemia. Horm Res 1996;46:195-201.
53. Muller HL. Oh Y. Gargosky SE. Lehrenbecher T. Hintz RL. Rosenfeld RG; Concentrations of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3), IGF. and IGFBP-3 protease activity in cerebrospinal lluid of children with leukemia, central nervous system tumor, or meningitis. J Clin Endocrinol Metab 1993:77: 1113-1119.
54. Kanety H, Madjar Y, Dagan Y. Levi J. Papa MZ, Pariente C. Goldwasser B. Karasik A: Serum insulin-like growth factor-binding pro-tein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: Correlation with scrum prostate-specific antigen. J Clin Endocrinol Mctab 1993:77:229-233.